Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $334.63M.
ENTERPRISE VALUE (EV)
$334.63M
Arvinas, Inc.
Market Cap
$477.13M
Enterprise Value (EV)
$334.63M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Arvinas, Inc. (ARVN) | $477.13M | $334.63M |
| Cerus Corporation (CERS)vs › | $475.60M | $534.42M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | $255.14M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $471.02M | $462.88M |
| Kamada Ltd. (KMDA)vs › | $469.63M | $451.96M |
| Sight Sciences, Inc. (SGHT)vs › | $468.08M | $430.30M |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.34M | $454.62M |
| Evolus, Inc. (EOLS)vs › | $487.98M | $607.62M |
| NRC Health (NRC)vs › | $459.97M | $546.68M |
| Oculis Holding AG (OCS)vs › | $496.80M | $499.93M |
Market Cap
$477.13M
Total Debt
$400000.00
Cash
$142.90M
Enterprise Value
$334.63M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
